BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 29190254)

  • 1. Fibrinolysis shutdown is associated with a fivefold increase in mortality in trauma patients lacking hypersensitivity to tissue plasminogen activator.
    Moore HB; Moore EE; Huebner BR; Dzieciatkowska M; Stettler GR; Nunns GR; Lawson PJ; Ghasabyan A; Chandler J; Banerjee A; Silliman C; Sauaia A; Hansen KC
    J Trauma Acute Care Surg; 2017 Dec; 83(6):1014-1022. PubMed ID: 29190254
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Overwhelming tPA release, not PAI-1 degradation, is responsible for hyperfibrinolysis in severely injured trauma patients.
    Chapman MP; Moore EE; Moore HB; Gonzalez E; Gamboni F; Chandler JG; Mitra S; Ghasabyan A; Chin TL; Sauaia A; Banerjee A; Silliman CC
    J Trauma Acute Care Surg; 2016 Jan; 80(1):16-23; discussion 23-5. PubMed ID: 26491796
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dense and dangerous: The tissue plasminogen activator-resistant fibrinolysis shutdown phenotype is due to abnormal fibrin polymerization.
    Dow N; Coleman JR; Moore H; Osborn ZT; Sackheim AM; Hennig G; Butenas S; Nelson MT; Moore EE; Freeman K
    J Trauma Acute Care Surg; 2020 Feb; 88(2):258-265. PubMed ID: 31999655
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Viscoelastic measurements of platelet function, not fibrinogen function, predicts sensitivity to tissue-type plasminogen activator in trauma patients.
    Moore HB; Moore EE; Chapman MP; Gonzalez E; Slaughter AL; Morton AP; D'Alessandro A; Hansen KC; Sauaia A; Banerjee A; Silliman CC
    J Thromb Haemost; 2015 Oct; 13(10):1878-87. PubMed ID: 26256459
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Plasmin thrombelastography rapidly identifies trauma patients at risk for massive transfusion, mortality, and hyperfibrinolysis: A diagnostic tool to resolve an international debate on tranexamic acid?
    Barrett CD; Moore HB; Vigneshwar N; Dhara S; Chandler J; Chapman MP; Sauaia A; Moore EE; Yaffe MB
    J Trauma Acute Care Surg; 2020 Dec; 89(6):991-998. PubMed ID: 33230046
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Window of Opportunity to Mitigate Trauma-induced Coagulopathy: Fibrinolysis Shutdown not Prevalent Until 1 Hour Post-injury.
    Leeper CM; Strotmeyer SJ; Neal MD; Gaines BA
    Ann Surg; 2019 Sep; 270(3):528-534. PubMed ID: 31305285
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differentiating Pathologic from Physiologic Fibrinolysis: Not as Simple as Conventional Thrombelastography.
    Moore HB; Barrett CD; Moore EE; Pieracci FM; Sauaia A
    J Am Coll Surg; 2024 Jul; 239(1):30-41. PubMed ID: 38299576
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Abnormalities in fibrinolysis at the time of admission are associated with deep vein thrombosis, mortality, and disability in a pediatric trauma population.
    Leeper CM; Neal MD; McKenna C; Sperry JL; Gaines BA
    J Trauma Acute Care Surg; 2017 Jan; 82(1):27-34. PubMed ID: 27779597
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Persistent fibrinolysis shutdown is associated with increased mortality in traumatic pancreatic injury.
    Liu B; Yang C; Deng Y; Duan Z; Wang K; Li J; Ding W
    Injury; 2023 May; 54(5):1265-1270. PubMed ID: 36774266
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Trending Fibrinolytic Dysregulation: Fibrinolysis Shutdown in the Days After Injury Is Associated With Poor Outcome in Severely Injured Children.
    Leeper CM; Neal MD; McKenna CJ; Gaines BA
    Ann Surg; 2017 Sep; 266(3):508-515. PubMed ID: 28650356
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Analysis of fibrinolytic shutdown in trauma patients with traumatic brain injury.
    Favors L; Harrell K; Miles V; Hicks RC; Rippy M; Parmer H; Edwards A; Brown C; Stewart K; Day L; Wilson A; Maxwell R
    Am J Surg; 2024 Jan; 227():72-76. PubMed ID: 37802703
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Harmful or Physiologic: Diagnosing Fibrinolysis Shutdown in a Trauma Cohort With Rotational Thromboelastometry.
    Gomez-Builes JC; Acuna SA; Nascimento B; Madotto F; Rizoli SB
    Anesth Analg; 2018 Oct; 127(4):840-849. PubMed ID: 29683829
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Does Tranexamic Acid Improve Clot Strength in Severely Injured Patients Who Have Elevated Fibrin Degradation Products and Low Fibrinolytic Activity, Measured by Thrombelastography?
    Moore HB; Moore EE; Chapman MP; Hansen KC; Cohen MJ; Pieracci FM; Chandler J; Sauaia A
    J Am Coll Surg; 2019 Jul; 229(1):92-101. PubMed ID: 30936005
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fibrinolysis greater than 3% is the critical value for initiation of antifibrinolytic therapy.
    Chapman MP; Moore EE; Ramos CR; Ghasabyan A; Harr JN; Chin TL; Stringham JR; Sauaia A; Silliman CC; Banerjee A
    J Trauma Acute Care Surg; 2013 Dec; 75(6):961-7; discussion 967. PubMed ID: 24256667
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Redefining postinjury fibrinolysis phenotypes using two viscoelastic assays.
    Stettler GR; Moore EE; Moore HB; Nunns GR; Silliman CC; Banerjee A; Sauaia A
    J Trauma Acute Care Surg; 2019 Apr; 86(4):679-685. PubMed ID: 30562328
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Systemic hyperfibrinolysis after trauma: a pilot study of targeted proteomic analysis of superposed mechanisms in patient plasma.
    Banerjee A; Silliman CC; Moore EE; Dzieciatkowska M; Kelher M; Sauaia A; Jones K; Chapman MP; Gonzalez E; Moore HB; D'Alessandro A; Peltz E; Huebner BE; Einerson P; Chandler J; Ghasabayan A; Hansen K
    J Trauma Acute Care Surg; 2018 Jun; 84(6):929-938. PubMed ID: 29554044
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Elucidating the molecular mechanisms of fibrinolytic shutdown after severe injury: The role of thrombin-activatable fibrinolysis inhibitor.
    Coleman JR; Moore EE; Kelher MR; Jones K; Cohen MJ; Banerjee A; Silliman CC
    J Trauma Acute Care Surg; 2023 Jun; 94(6):857-862. PubMed ID: 36787438
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hyperfibrinolysis at admission is an uncommon but highly lethal event associated with shock and prehospital fluid administration.
    Cotton BA; Harvin JA; Kostousouv V; Minei KM; Radwan ZA; Schöchl H; Wade CE; Holcomb JB; Matijevic N
    J Trauma Acute Care Surg; 2012 Aug; 73(2):365-70; discussion 370. PubMed ID: 22846941
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Human neutrophil elastase mediates fibrinolysis shutdown through competitive degradation of plasminogen and generation of angiostatin.
    Barrett CD; Moore HB; Banerjee A; Silliman CC; Moore EE; Yaffe MB
    J Trauma Acute Care Surg; 2017 Dec; 83(6):1053-1061. PubMed ID: 28837538
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Thrombin Provokes Degranulation of Platelet α-Granules Leading to the Release of Active Plasminogen Activator Inhibitor-1 (PAI-1).
    Huebner BR; Moore EE; Moore HB; Stettler GR; Nunns GR; Lawson P; Sauaia A; Kelher M; Banerjee A; Silliman CC
    Shock; 2018 Dec; 50(6):671-676. PubMed ID: 29280928
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.